Sizzling Stock Alert: CVS Health Corporation (CVS)

Roberts Jonathan C also sold $4.90 million worth of CVS Health Corp (NYSE:CVS) shares. Seven investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. On Monday, August 10 the stock rating was maintained by Argus Research with "Buy".

A number of brokerages have weighed in on CVS.

Now the shares of CVS Health Corporation (CVS) has a trading volume of 7.31 Million shares, with an average trading volume of 6880 shares - with shares dropping to a 52 week low of $68.44, and the company's shares hitting a 52 week high of $ 100.20.

Several equities research analysts have recently commented on the company.

In the most recent trading session, CVS Health Corporation (NYSE:CVS) shares saw a move of -0.3914%. Watching a firm's EV may be useful when comparing companies with different capital structures. Jefferies Group LLC set a $82.00 target price on shares of CVS Health Corp and gave the stock a "hold" rating in a research note on Saturday, April 1st. CVS Health Corp accounts for 1.4% of Howland Capital Management LLC's investment portfolio, making the stock its 29th largest position.

Media stories about CVS Health Corp (NYSE:CVS) have trended positive recently, Alpha One Sentiment reports. CVS Health Corporation (CVS) now trades with a market capitalization of $80.07 Billion. CVS Health Corp (NYSE:CVS) has risen 6.00% since April 19, 2017 and is uptrending. Many traders watch for long-term averages to cross above short-term averages to signal the beginning of a downtrend Upon corrections, the price will meet resistance from the averages between $79.42 and $79.44.

CVS Health Corp (NYSE:CVS) last released its earnings results on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.07. The company had revenue of $44.51 billion for the quarter, compared to analyst estimates of $44.20 billion. CVS Health Corp had a return on equity of 17.55% and a net margin of 3.00%. CVS Health Corp's revenue for the quarter was up 3.0% compared to the same quarter a year ago.

Looking forward, the company is expected to report earnings of $1.31 per share for the current quarter.

The firm also recently announced a quarterly dividend, which was paid on Monday, May 1st. Wealthtrust Fairport Ltd Liability Company invested in 0.05% or 5,661 shares. The ex-dividend date of this dividend was Wednesday, April 19th. CVS Health Corp's dividend payout ratio (DPR) is now 40.65%. Vetr raised CVS Health Corp from a "buy" rating to a "strong-buy" rating and set a $85.96 price objective for the company in a report on Wednesday.

"COPYRIGHT VIOLATION NOTICE: "[[title]]" was reported by [[site]] and is owned by of [[site]]. The correct version of this piece of content can be accessed at https://sportsperspectives.com/2017/05/19/cvs-health-corp-cvs-shares-bought-by-howland-capital-management-llc-updated.html. $5.99M worth of CVS Health Corp (NYSE:CVS) shares were sold by MERLO LARRY J. On Monday, March 13 the insider Sussman Andrew sold $1.13 million. The stock was sold at an average price of $79.60, for a total value of $479,908.40. Following the transaction, the executive vice president now owns 89,955 shares in the company, valued at $7,196,400. The transaction was disclosed in a document filed with the SEC, which is available through this link. The shares were sold at an average price of $80.68, for a total transaction of $7,714,460.24. Following the sale, the chief financial officer now directly owns 250,335 shares in the company, valued at $20,197,027.80. The disclosure for this sale can be found here. Using a scale from 0 to 100, a lower score would represent an undervalued company and a higher score would indicate an expensive or overvalued company. It is negative, as 135 investors sold CVS shares while 627 reduced holdings. Finally, First City Capital Management Inc. increased its stake in CVS Health Corp by 0.3% in the first quarter.

The stock added in the prior trading session by 0.38%, closing at the stock price of $76.62. Arcadia Investment Management Corp MI now owns 1,700 shares of the pharmacy operator's stock worth $151,000 after buying an additional 95 shares during the period.

Strategic Financial Services Inc increased Cvs Health Corporation (CVS) stake by 49.92% reported in 2016Q4 SEC filing. Illinois-based Chesley Taft And Associate Ltd Liability has invested 0.17% in CVS Health Corp (NYSE:CVS). ROIC may be a good measure to view when examining whether or not a company is able to invest wisely.

About CVS Health Corp CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company.

Latest News